-
Most Popular
Search Results
240 results for abv
Trade of the Day: AbbVie Inc. (NYSE:ABBV)
AbbVie has a great opportunity for growth in developing and commercialize BioArctic’s treatment platform for neurodegenerative diseases.
AbbVie Inc (ABBV) Is About to Steamroll the Competition
Good news for AbbVie (ABBV) shareholders: The pharmaceutical company just entered the Hepatitis C. market, while reinforcing its position in the psoriasis area. Given ABBV’s…
ABBV Stock Slips as AbbVie Faces Opioid Lawsuits
AbbVie’s quarterly results were roughly in line with Wall Street’s expectations, but ABBV stock still slipped in early trading.
JD.com Stock Should Be Able to Soar Above $50
JD stock has been troubled for several years now, but the long-term growth outlook is steadily improving – thanks to global retail expansion, a tailwind…
Superior Earnings Momentum Keeps AbbVie (ABBV) a Buy
AbbVie Inc (NYSE:ABBV) is one of 345 companies within the Biotechnology GICS industry group, which is in turn part of the 782 company GICS Health…
AbbVie Inc (ABBV) Earnings: 12 Things to Know
AbbVie (ABBV) has released its earnings report for the third quarter of 2017 and ‘InvestorPlace’ has a few things to know about it.
Biggest Movers in Services Stocks Now – ARE CCO AVB AIV
Services stocks finished down broadly on Wall Street on Monday, with the sector seeing an overall decline of 0.5%.
AbbVie Inc (ABBV) Has More Blockbusters on the Horizon
AbbVie (ABBV) isn’t just resting on the success of Humira; this major pharmaceutical firm is building for a long, strong future.
ABBV: AbbVie Beats Street on Soaring Humira Sales
Pharmaceutical-maker AbbVie posted first-quarter sales that beat estimates on surging sales of its Humira drug, sending ABBV stock higher.
AI Is Coming for a Surprising Industry
For pharma companies, the soaring price of drug development comes with real costs. In fact, the situation is so bad that researchers have taken to calling…
The Fed Gave the Green Light for Stocks to Rally This Week
While AI stocks were whipsawing up and down due to DeepSeek, the rest of the market quietly powered higher because of the Fed.
AbbVie Earnings: ABBV Stock Falters on Q4 Miss
AbbVie earnings for the fourth quarter of 2018 saw ABBV stock falling today after reporting an earnings per share and revenue miss.
AbbVie Earnings: 5 Things for ABBV Stock Investors to Note
AbbVie (ABBV) earnings for the biopharmaceutical company’s third quarter of 2019 have ABBV stock up Friday on an EPS and revenue beat.
AbbVie Earnings: ABBV Stock Pops on Q2 Beat
AbbVie earnings for the second quarter of 2019 have ABBV stock up on Friday thanks to it beating EPS and revenue estimates.
AbbVie (ABBV) a Strong Buy on Top-End Earnings Momentum
Portfolio Grader currently ranks AbbVie Inc (NYSE:ABBV) a Strong Buy. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis…
Earnings Momentum Analytics Power AbbVie (ABBV) to Strong Buy
The current recommendation of Strong Buy for AbbVie Inc (NYSE:ABBV) has been derived by using Louis Navellier’s Portfolio Grader stock evaluator, which incorporates his investing…
AbbVie (ABBV) a Strong Buy on Best-in-Class Quant Score
AbbVie Inc (NYSE:ABBV) is a constituent of the 350 company Biotechnology GICS industry group, which is a segment of the 782 company GICS Health Care…
Why AbbVie Inc Was a Named Top Dividend Stock (ABBV)
AbbVie Inc has been named to the Dividend Channel’s SAFE dividend list based upon these key metrics
10 Best “Strong Buy” Stocks — ABG ABT ACHC and more
This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance. Since the beginning of the year,…
AbbVie Earnings: ABBV Stock Jumps More Than 6% on Q4 Beats
AbbVie (ABBV) earnings for the biopharmaceutical company’s fourth quarter of 2019 have ABBV stock heading higher on Friday.
Trade of the Day: ABBV Stock on the Verge of a Major Breakout
AbbVie Inc is challenging the recent double-top above $65.
DeepSeek Has Big Tech Sweating, But Investors Should Stay Cool
Many fear the DeepSeek breakthrough means the end of Big Tech or the AI industry, but we think that couldn’t be further from the truth.
AbbVie Stock News: Why ABBV Is the Top Trending Ticker Today
AbbVie stock is the top trending ticker on Yahoo Finance Thursday earnings news has ABBV investors pumped up this morning.
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
ABBV stock has rightly earned its place among the Best Stocks for 2022. This Dividend King is outperforming the S&P 500.
8 – 10 of 240 results
